Dual bronchodilators have been shown to broadly improve symptoms and quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD). In patients with chronic obstructive pulmonary ...

In addition to pharmacologic interventions and oxygen, there are a number of nonpharmacologic strategies that can be beneficial in the management of dyspnea. By changing a patient's physical ...

Patients with a rare, deadly disease that mostly affects young women felt a dramatic reduction in breathlessness using an approved drug, according to study results published online today in The ...

Sophia-Antipolis, 9 December 2021: A small study has suggested that COVID-19 patients who continue to be short of breath during physical activity one year after recovering from the infection may have ...

A small study has suggested that COVID-19 patients who continue to be short of breath during physical activity one year after recovering from the infection may have suffered heart damage. The research ...

Wheezing after getting on the treadmill. Gulping down air while doing chores. Breathlessness is one of the many scary and frustrating symptoms that can linger in Covid patients months after their ...

Long-lasting immune activity in the airways might be the cause of persistent breathlessness following COVID-19, according to new research. Long-lasting immune activity in the airways might be the ...

Among patients with chronic obstructive pulmonary disease (COPD) and severe chronic breathlessness, short-term daily treatment with low doses of extended-release morphine did not significantly reduce ...

Sometimes healthcare professionals treat patients with opioids such as morphine to relieve symptoms, but there has been a lack of evidence as to whether this helps with severe chronic breathlessness.

Although not every patient who presents with dyspnea will have coexisting heart and lung diseases, it is estimated that between 20% and 30% of patients who have HF have comorbid COPD. 3 While there ...